Shareholders approve NHL property purchase and full divestment

Capex & Operations View source PDF Explain this filing

THYROCARE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-11.9%Reaction day

₹516.90

prior close

₹496.05

announcement price

After-mkt

timing

Nifty Microcap 250marketpendingvs market: pending

Healthcare Service Provider peers, median of 23sector-1.4%-10.5% vs sector

On the reaction day the stock moved 10.5 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.8

10m

-4.2

15m

-4.2

30m

-2.9

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-11.9pendingpending-1.4-10.5

Next day

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 23Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Shareholders passed two postal ballot resolutions. Buying land and a building from Nueclear Healthcare Limited was approved with 99.9997% of votes in favour. Selling the company’s entire stake in Nueclear Healthcare to Trovera Healthcare Private Limited was approved by 92.92% of all votes and 81.67% of public shareholder votes. No transaction value was disclosed.

Likely market impact

Approvals clear the property purchase and full sale of Nueclear Healthcare. The filing gives no value or proceeds, so the effect on earnings and cash flow is unclear.